BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gavioli EC, Holanda VAD, Calo G, Ruzza C. Nociceptin/orphanin FQ receptor system blockade as an innovative strategy for increasing resilience to stress. Peptides 2021;141:170548. [PMID: 33862163 DOI: 10.1016/j.peptides.2021.170548] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Himcheva I, Stavreva GT, Naydenova E, Bocheva A. Involvement of the opioidergic and nociceptinergic systems in the analgesic effects of novel nociceptin analogues after acute and chronic immobilization stress. PHAR 2022;69:935-942. [DOI: 10.3897/pharmacia.69.e89379] [Reference Citation Analysis]
2 D'oliveira da Silva F, Azevedo Neto J, Sturaro C, Guarino A, Robert C, Gavioli EC, Calo G, Mouledous L, Ruzza C. The NOP antagonist BTRX-246040 increases stress resilience in mice without affecting adult neurogenesis in the hippocampus. Neuropharmacology 2022. [DOI: 10.1016/j.neuropharm.2022.109077] [Reference Citation Analysis]
3 Al Yacoub ON, Awwad HO, Zhang Y, Standifer KM. Therapeutic potential of nociceptin/orphanin FQ peptide (NOP) receptor modulators for treatment of traumatic brain injury, traumatic stress, and their co-morbidities. Pharmacol Ther 2021;:107982. [PMID: 34480968 DOI: 10.1016/j.pharmthera.2021.107982] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]